Clinical Trial

Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment

Completed Phase 4
View on ClinicalTrials.gov →
Summary
Among US veterans, migraine is a prevalent and disabling neurological disorder, creating a clinical need for effective treatment options. This real-world evidence (RWE) study assessed the use, effectiveness, and safety of the REN wearable for the acute treatment of migraine among veterans, with a primary focus on whether they need rescue medications following REN treatment. Findings from this study may help guide clinical decision-making as veterans and providers craft treatment plans that include non-pharmacologic options.
Protocol Amendment History 2 changes
critical Trial status changed: Enrolling by Invitation → Completed 2026-04-04
notable Enrollment reduced: 600 -> 466 participants 2026-04-04
Trial Details
NCT Number NCT07336420
Lead Sponsor Theranica
Conditions Migraine, Acute Treatment of Migraine
Enrollment 466 participants
Start Date 2026-01-09
Primary Completion 2026-01-25 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-03